Cancer Letters · 2017 · 42 citations · 126 references
MedicineOncologyUrologyMolecular OncologyPrecision OncologyUrologic OncologyAndrogen TherapyHormonal TherapyProstate CancerSteroid Hormone SignalingTargeted Cancer TherapyTargeted TherapyAndrogen Receptor ExpressionAndrogen Receptor TargetingAndrogen ReceptorsAndrogen ResistanceCastration-resistant Prostate Cancer Therapy
126
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher, Karim Fizazi, Fred Saad et al. · New England Journal of Medicine · 2012 · 4.6K citations · Full text
Medicine, Oncology, Pharmacology +14
Abiraterone and Increased Survival in Metastatic Prostate Cancer
Johann S. de Bono, Christopher J. Logothetis, Arturo Molina et al. · New England Journal of Medicine · 2011 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +17
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang et al. · New England Journal of Medicine · 2014 · 2.7K citations · Full text
Medicine, Oncology, Pharmacology +17
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran, Samedy Ouk, Nicola J. Clegg et al. · Science · 2009 · 2.3K citations · Full text